For older adults facing major surgery, the choice of anesthesia method has long been assumed to be largely interchangeable from a recovery standpoint. A large randomized trial now puts that assumption to a rigorous test — with implications for millions of surgeries performed annually on aging populations.
The trial, published in JAMA, compared total intravenous anesthesia (TIVA), primarily propofol-based, against volatile inhalational agents in older adults undergoing major noncardiac procedures. The primary endpoint was a composite measure of days alive and at home within 30 days of surgery — a patient-centered metric that captures both mortality and functional recovery rather than isolated clinical events. The trial enrolled a sufficiently powered cohort to detect clinically meaningful differences between the two modalities across this outcome, with secondary endpoints likely encompassing delirium, cognitive function, and complication rates.
This research enters a contested space. Observational data and smaller trials have intermittently suggested that TIVA may reduce postoperative nausea and vomiting and potentially lower the incidence of postoperative cognitive dysfunction — a concern of particular relevance in patients over 65, whose neurological resilience is reduced. Volatile agents such as sevoflurane have dominated surgical suites for decades due to ease of titration and cost, but their metabolic byproducts and effects on cerebral autoregulation have drawn scrutiny. What makes this trial notable is its randomized design and its use of a functional recovery endpoint rather than purely surrogate markers, lending greater translational weight to its conclusions. Key limitations to consider include potential variability in anesthetic management protocols across sites and the challenge of blinding in anesthesia trials. Whether findings will shift institutional preferences depends heavily on effect size and the consistency of subgroup results across age bands and procedure types. This is a clinically significant contribution to perioperative medicine.